Nantong Diagnos Biotechnology Co., Ltd. specializes in the development and manufacturing of point-of-care testing (POCT) medical instruments and in-vitro diagnostic products. Established in 2006, the company focuses on a wide range of diagnostic specialties, including fertility, infectious diseases, tumor markers, cardiac markers, and drug abuse tests. Their product offerings include advanced testing kits such as the Covid-19 Test Kit, various tests for tropical viruses, and a range of assays for both human and animal health. The company has achieved ISO certifications, indicating a commitment to quality management and product safety.

The technologies employed by Diagnos encompass fluorescence immunoassay testing, which is utilized in many of their diagnostic kits. This method allows for the sensitive detection of biomarkers in various medical conditions, enhancing the accuracy and reliability of test results. Additionally, Diagnos provides a diverse array of test kits, including those for canine diseases and specific human health markers, such as hemoglobin A1c and thyroid-stimulating hormone. Their focus on innovation and quality positions them as a significant player in the biotechnology sector, particularly in the realm of rapid diagnostic testing.

China

Nantong Diagnos Biotechnology Co., Ltd. (Diagnos) is a professional POCT(point-of-care testing) manufacturer in China, found in 2006, specialized in researching, developing, manufacturing and distributing advanced medical instruments and in-vitro medical diagnostic products. Diagnos offers quality products in the following specialties: Fertility, Infectious Diseases, Tumor Markers, Cardiac Markers, Substance of Drug Abuse tests and etc.(2019-nCoV) New coronavirus Antibody Test (Colloidal Gold)

Nantong Diagnos Biotechnology

Company Details